BRIEF published on 08/27/2024 at 13:05, 1 year 3 months ago Pharnext begins liquidation proceedings Creditors Liquidation Paris Commercial Court Pharnext Suspension Of Listing
BRIEF published on 08/27/2024 at 13:05, 1 year 3 months ago Pharnext entame une procédure de liquidation judiciaire Liquidation Judiciaire Tribunal De Commerce De Paris Suspension De Cotation Pharnext Créditeurs
PRESS RELEASE published on 08/27/2024 at 13:00, 1 year 3 months ago Ouverture d'une procédure de liquidation judiciaire Pharnext SCA, société biopharmaceutique en liquidation judiciaire après procédure de conciliation. Suspension de la cotation des actions Biopharmaceutique Liquidation Judiciaire Suspension Cotation Pharnext Procédure Conciliation
BRIEF published on 07/04/2024 at 20:05, 1 year 5 months ago Pharnext announces the termination of the financing contract granted by Néovacs Investors Termination Funding Pharnext Néovacs
BRIEF published on 07/04/2024 at 20:05, 1 year 5 months ago Pharnext annonce la résiliation du contrat de financement accordé par Néovacs Financement Investisseurs Pharnext Résiliation Néovacs
PRESS RELEASE published on 07/04/2024 at 20:00, 1 year 5 months ago Pharnext annonce la résiliation du contrat de financement accordé par Néovacs Pharnext annonce la résiliation anticipée du contrat de financement avec Néovacs suite à des cas de défaut. La société sollicite Global Tech Opportunities 13 pour son soutien Financement Pharnext Résiliation Néovacs Global Tech Opportunities
BRIEF published on 06/18/2024 at 18:35, 1 year 5 months ago Pharnext annonce la prorogation de la procédure de conciliation jusqu'au 15 juillet 2024 Pharnext Procédure De Conciliation CMT1A PXT3003 Tasly
BRIEF published on 06/18/2024 at 18:35, 1 year 5 months ago Pharnext announces the extension of the conciliation procedure until July 15, 2024 Pharnext Conciliation Procedure CMT1A PXT3003 Tasly
PRESS RELEASE published on 06/18/2024 at 18:30, 1 year 5 months ago Pharnext annonce la prorogation de la procédure de conciliation jusqu'au 15 juillet 2024 Pharnext annonce la prorogation de la procédure de conciliation jusqu'au 15 juillet 2024 pour poursuivre l'étude clinique de Phase III de PXT3003. Les résultats seront communiqués prochainement Conciliation Étude Clinique Pharnext PXT3003 Maladie Neurodégénérative
BRIEF published on 05/07/2024 at 19:15, 1 year 7 months ago Adjustment of the nominal value at Pharnext Biopharmaceutical Capital Reduction Pharnext Nominal Value Neurodegenerative Diseases
Published on 12/18/2025 at 13:35, 8 minutes ago CBMJ: The JD Rucker Show Returns to Patriot.TV - "2026 Is a Pivotal Year for America" - Reuniting Network with Flagship Voice Ahead of Defining Election Cycle
Published on 12/18/2025 at 13:30, 13 minutes ago Orogen Royalties Reports Continued Exploration Success on Ermitaño Royalty AOI
Published on 12/18/2025 at 13:30, 13 minutes ago Quartz Completes Induced Polarization Geophysical Survey At Maestro Project, British Columbia
Published on 12/18/2025 at 06:25, 7 hours 18 minutes ago 1933 Industries Announces Maturity of Unsecured Convertible Debentures and Encourages Conversion to Support Continued Growth
Published on 12/18/2025 at 13:38, 4 minutes ago 2CRSi SA: Information mensuelle relative au nombre total de droits de vote Et d’actions composant le capital social au 30 septembre 2025
Published on 12/18/2025 at 13:15, 28 minutes ago Warburg Pincus attains 82.35% of all PSI shares - Additional Acceptance Period for Public Takeover Offer for PSI commences
Published on 12/18/2025 at 12:59, 43 minutes ago EQS-Adhoc: Wolford AG: Wolford announces that a capital decrease has become effective
Published on 12/18/2025 at 10:00, 3 hours 43 minutes ago Neoen remporte 124 MWc de projets solaires en France
Published on 12/17/2025 at 20:39, 17 hours 4 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 17 hours 4 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 18 hours 13 minutes ago Evolution de la composition du Conseil d’Administration
